The study analyzed 283 discogenic lower back pain cases from eight articles from Pubmed and ScienceDirect up to Sept. 13, 2023. Researchers measured clinical outcomes with the visual analog scale and Oswestry Disability Index.
Functional outcomes in stem cell therapy patients showed significant improvement in both measures, and subgroup analysis for bone marrow aspirate concentrate showed similar improvements.
The study concluded, “Stem cell therapy could be beneficial as an option of treatment for discogenic LBP in improving pain and activity of daily living.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
